Q/C Technologies, Inc. (QCLS) Fair Value 2026

QCLS · In Vitro & In Vivo Diagnostic Substances ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.9 /10

32 fundamental signals · 7 models active

Value Trap Risk

WARN (40/100)

Quick Summary — As of 2026-07-15, Q/C Technologies, Inc. (QCLS) trades at $3.48, approximately 238% above CirclFi’s Bayesian DCF fair value of $1.03. QOC: 3.9/10. Value Trap Risk: 40/100 (WARN). 7/13 models active.

Key Facts

Ticker
QCLS
Price
$3.48
Quality Score
3.9/10
Value Trap Risk
40/100
Models Active
7/13
Last Updated
Strength: First Chicago suggests +86.8% upside with 15% confidence
Risk: Value Trap score of 40 suggests caution despite apparent undervaluation

Is Q/C Technologies, Inc. (QCLS) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, Q/C Technologies, Inc. (QCLS) appears overvalued as of : the median of 7 independent fair value estimates is $2.04, 41.5% below the current price of $3.48. Estimates range from $0.11 to $6.50. QCLS scores 3.9/10 on fundamental quality and 40/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Q/C Technologies, Inc. Stock in 2026? →

Valuation Matrix

7 Intrinsic Value Models vs. Current Price ($3.48)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $1.03 -70.4%
CUCE Ensemble
Low Conviction
 $2.04 -41.5%
First Chicago
Low Conviction
 $6.50 +86.8%

Unlock the Full Matrix

Access 4 additional models including ML-RIV, Dynamic NAV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is Q/C Technologies, Inc. (QCLS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Q/C Technologies, Inc. at its current price of $3.48. The composite intrinsic value is estimated at $2.53 (-27.2% average return), with 4 models flagging overvaluation risk. Notably, First Chicago sees the most upside at +86.8% (fair value: $6.50), while Dynamic NAV is the most conservative at -96.9% ($0.11). The spread between these extremes — +183.6% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About QCLS?

7 of 13 models are currently active for QCLS. Of these, 3 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates QCLS's intrinsic value at $1.03, implying -70.4% downside from the current price. See which stocks rank higher →

How Does QCLS Rank in In Vitro & In Vivo Diagnostic Substances?

Among 17 In Vitro & In Vivo Diagnostic Substances stocks, QCLS ranks #15 by Quality of Company score. CirclFi's QOC score of 3.9/10 evaluates 32 fundamental signals. A score of 3.9 signals below-average fundamentals.

Q/C Technologies, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is QCLS a Value Trap?

CirclFi's Value Trap algorithm assigns QCLS a score of 40/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for Q/C Technologies, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Q/C Technologies, Inc. is rated at 3.9/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

The gap between the most bullish and bearish model spans +183.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every QCLS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across QCLS's 7 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Q/C Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar In Vitro & In Vivo Diagnostic Substances Stocks Should You Also Analyze?

8 related In Vitro & In Vivo Diagnostic Substances stocks with 13-model coverage

IDXXIDEXX Laboratories, Inc.QOC 10.0LNTHLantheus Holdings, Inc.QOC 10.0NEOGNeogen CorporationQOC 7.6ICCCImmuCell CorporationQOC 7.2QDELQuidelOrtho CorporationQOC 6.9NTLAIntellia Therapeutics, Inc.QOC 6.2CLDXCelldex Therapeutics, Inc.QOC 6.1VNRXVolitionRX LimitedQOC 6.1

Read investment analysis: IDXX · LNTH · NEOG · ICCC · QDEL

Frequently Asked Questions About Q/C Technologies, Inc.

What is Q/C Technologies, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Q/C Technologies, Inc. (QCLS) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $1.03. The Quality of Company score is 3.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is QCLS overvalued or undervalued right now?

At $3.48, 3 of 7 active models suggest QCLS may be undervalued, while 4 indicate potential overvaluation. The median of all 7 fair value estimates is $2.04, 41.5% below the current price of $3.48 — a consensus view that QCLS is overvalued. The assessment depends on which methodology best fits Q/C Technologies, Inc.'s business model in In Vitro & In Vivo Diagnostic Substances.

What does a Quality of Company score of 3.9 mean for QCLS?

Q/C Technologies, Inc.'s QOC of 3.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on QCLS?

CirclFi analyzes QCLS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Is QCLS a value trap in 2026?

Q/C Technologies, Inc.'s Value Trap score is 40/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 7-model valuation engine, Q/C Technologies, Inc. (QCLS) has a median fair value of $2.04 — 41.5% below the current price of $3.48 — as of 2026-07-15.” Source: circlfi.com/stock/QCLS/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on QCLS.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access